Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Xvivo Perfusion AB's share price for the quarter that ended in Mar. 2024 was kr275. Xvivo Perfusion AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 31.5 Mil. Therefore, Xvivo Perfusion AB's market cap for the quarter that ended in Mar. 2024 was kr8,662.2 Mil.
Xvivo Perfusion AB's quarterly market cap
increased
from Sep. 2023 (kr8,646.6 Mil) to Dec. 2023 (kr10,379.1 Mil) but then
declined
from Dec. 2023 (kr10,379.1 Mil) to Mar. 2024 (kr8,662.2 Mil).
Xvivo Perfusion AB's annual market cap
declined
from Dec. 2021 (kr8,215.4 Mil) to Dec. 2022 (kr5,459.2 Mil) but then
increased
from Dec. 2022 (kr5,459.2 Mil) to Dec. 2023 (kr10,379.1 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Xvivo Perfusion AB's Enterprise Value for Today is kr9,597.0 Mil.
Xvivo Perfusion AB Market Cap Historical Data
The historical data trend for Xvivo Perfusion AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Xvivo Perfusion AB's Market Cap
For the Medical Devices subindustry, Xvivo Perfusion AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xvivo Perfusion AB's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Xvivo Perfusion AB's Market Cap falls into.
Xvivo Perfusion AB Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Xvivo Perfusion AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xvivo Perfusion AB (OSTO:XVIVO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Xvivo Perfusion AB Market Cap Related Terms
Thank you for viewing the detailed overview of Xvivo Perfusion AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Xvivo Perfusion AB (OSTO:XVIVO) Business Description
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:XVIVO has been successfully added to your 